share_log

P3 Health Partners Names Aric Coffman CEO, Effective May 8, 2024, Succeeding Sherif Abdou, P3's Co-Founder

P3 Health Partners Names Aric Coffman CEO, Effective May 8, 2024, Succeeding Sherif Abdou, P3's Co-Founder

P3 Health Partners任命阿里克·科夫曼爲首席執行官,自2024年5月8日起生效,接替P3的聯合創始人謝里夫·阿卜杜
Benzinga ·  05/09 05:12

P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3's Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company's Board of Directors working closely with Dr. Coffman to ensure a smooth transition.

P3 Health Partners Inc.(“P3” 或 “公司”)(納斯達克股票代碼:PIII)今天任命阿里克·科夫曼博士爲P3首席執行官,自2024年5月8日起生效,接替P3的聯合創始人謝里夫·阿卜杜博士。阿卜杜博士將繼續擔任P3的戰略顧問,並擔任公司董事會成員,與科夫曼博士密切合作,確保平穩過渡。

Dr. Coffman is an exceptional physician leader with a proven track record of success in the value-based care sector, most recently as the CEO of Honest Medical Group, a Rubicon Founders portfolio company. He brings over two decades of experience in leading provider organizations in delivering high quality, highly efficient healthcare delivery for seniors in the Medicare Advantage and ACO market. Prior to his tenure at Honest, Dr. Coffman was the CEO of the Everett Clinic and Northwest Physicians Network (Part of OptumCare) where he doubled MA membership and led them into the full risk DSNP market segment. During his tenure at Honest he successfully grew the company from start up to a multistate, multi-payer senior focused, provider enablement organization. Thanks to his prior experience working with members of our leadership team including Dr. Abdou, Dr. Amir Bacchus (Co-Founder & CMO) and Bill Betterman (COO), we are confident Dr. Coffman will be warmly welcomed by the P3 team.

科夫曼博士是一位傑出的醫師領導者,在基於價值的醫療領域有着良好的成功記錄,他最近擔任了Rubicon Founders投資組合公司Honest Medical Group的首席執行官。他在領先的提供者組織中擁有二十多年的經驗,爲Medicare Advantage和ACO市場的老年人提供高質量、高效的醫療服務。在Honest任職之前,科夫曼博士曾擔任埃弗雷特診所和西北醫師網絡(OptumCare的一部分)的首席執行官,在那裏他將併購會員人數翻了一番,帶領他們進入了全風險的DSNP細分市場。在Honest任職期間,他成功地將公司從初創企業發展成爲一家以多州、多付款人爲中心的高級提供商支持組織。由於他之前與包括阿卜杜博士、阿米爾·巴克斯博士(聯合創始人兼首席營銷官)和比爾·貝特曼(首席運營官)在內的領導團隊成員合作的經驗,我們相信科夫曼博士將受到P3團隊的熱烈歡迎。

"Sherif and I agree that now is the right time to bring in new leadership, and Dr. Aric Coffman is exceptionally well-suited to advance our long-term strategy," said Mark Thierer, P3's Chairman of the Board. "Aric is a respected and accomplished, growth-oriented leader with extensive management expertise and a great track record in the value-based care sector."

P3董事會主席馬克·蒂勒說:“謝里夫和我都同意,現在是引進新領導層的合適時機,阿里克·科夫曼博士特別適合推進我們的長期戰略。”“Aric是一位受人尊敬且成就卓著、以增長爲導向的領導者,擁有豐富的管理專業知識,在基於價值的護理領域有着良好的往績。”

"I am thrilled to join the amazing team of professionals and clinicians at P3 and to build on the successful foundation that Dr. Abdou and Dr. Bacchus have established. I believe deeply in the holistic value-based care delivery model that is enabled by Medicare Advantage and its ability to improve the quality of care for seniors," said Dr. Coffman.

“我很高興加入P3由專業人員和臨床醫生組成的優秀團隊,並在Abdou博士和Bacchus博士建立的成功基礎上再接再厲。我深信Medicare Advantage及其改善老年人護理質量的能力所支持的基於價值的整體護理提供模式,” 科夫曼博士說。

"I am extremely proud of and grateful to the team we have built at P3 Health Partners. We started P3 in 2017 and built the company into one of the leading value-based care platforms today," said Dr. Abdou. "It gives me great satisfaction to be able to attract someone of Dr. Coffman's reputation and accomplishment to lead P3's next chapter of growth and success."

“我爲我們在P3 Health Partners建立的團隊感到非常自豪和感激。我們在2017年創立了P3,並將公司打造成當今領先的基於價值的醫療平台之一。” Abdou博士說。“能夠吸引像科夫曼博士這樣聲譽和成就的人來引領P3的下一個增長和成功篇章,這讓我感到非常滿意。”

Mr. Thierer continued, "On behalf of the Board, I would like to welcome Dr. Coffman in as the new CEO of P3 Health Partners. I would also like to thank Dr. Abdou for his excellent service as CEO since 2017 and look forward to our continued work together on behalf of P3."

蒂勒繼續說:“我謹代表董事會歡迎科夫曼博士擔任P3 Health Partners的新任首席執行官。我還要感謝阿卜杜博士自2017年以來擔任首席執行官所提供的出色服務,並期待我們繼續代表P3合作。”

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論